Pfizer Inc.'s (JOBS) Bone-Drug Fablyn Fails to Win U.S. Approval

Jan. 16 (Bloomberg) -- Pfizer Inc., the world’s largest drugmaker, failed to win U.S. approval to sell a treatment for women with weak bones that may be linked to an increase in deaths.